The Calciphylaxis Market is projected to witness steady growth through 2034, driven by increasing awareness of rare diseases, advances in targeted therapeutic development, and improvements in diagnostic capabilities. Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare but life-threatening vascular disorder characterized by calcification of small blood vessels, tissue...